1 |
Canetti, G., Rist, N., and Grosset, J., Measure de la sensibilite du bacille tuberculeux aux drogues antibacillaires par la methode des proportions. Rev. Tuber., 58, 111-114 (1983)
|
2 |
Mahfouz, N. M., Omar, F. A., and Aboul-Fadl, T., Cyclic amide derivatives as potential prodrugs: N-hydroxymethy-succinimide-/isatin esters of some NSAIDs as chemical delivery system with improved therapeutic index. Eur. J. Med. Chem., 34, 551-562 (1999)
PUBMED
|
3 |
Majumdar, K. C., Kundu, A. K., and Chatterjee, P., 1-Alkylisatins via aldol-retro-aldol condensation. J. Chem. Research (S), 460-461 (1996)
|
4 |
Moss, J. and Bundgaard, H., Prodrugs of peptides. 7. Transdermal delivery of thyrotropin-releasing hormone (TRH) via prodrugs. Inter. J. Pharm., 66, 39-45 (1990)
DOI
ScienceOn
|
5 |
Radul, O. M., Zhungietu, G. I., Rekhter, M. A., and Bukhanyuk, S. M., Simple method for the synthesis of 1-substituted isatins. Khimiya Geterotsiklicheskikh Soedinenii, 3, 353-355 (1983)
|
6 |
Selvam, P., Chandramohan, M., De Clercq, E., Witvrouw, M., and Pannecouque, C., Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)-amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzenesulfonamide and its derivatives. European Journal of Pharmaceutical Sciences, 14, 313-316 (2001)
DOI
ScienceOn
|
7 |
Shargel, L. and Andrew, B. C. In Applied Biopharmaceutics and Pharmaceutics, 3rd. Ed., Prentice-Hall International Co., Appleton & Lange, London, p. 174 (1993)
|
8 |
Knotz, F., Production of antiviral and antimicrobial substances. 1. 1-Alkylisatin-3-acylhydrazones. Scientia Pharmaceutica, 38, 98-106 (1970)
|
9 |
Somogyi, L. Transformation of Isatin 3-acylhydrazones under acetylating conditions: synthesis and structure elucidation of 1,5-disubstituted 3-acetylspiro[oxindole-3,2-[1,3,4]oxadiazolines]. Bull. Chem. Soc. Jpn., 74, 873-881 (2001)
DOI
ScienceOn
|
10 |
Silva, J. F. M. D., Garden, S. J., and Pinto, A. C., The Chemistry of Isatins: a Review from 1975 to 1999, J. Braz. Chem. Soc., 12, 273-324 (2001)
DOI
ScienceOn
|
11 |
Piscopo, B., Diumo, M. V., Godliardi, R., Cucciniello, M., and Veneruso, G., Studies on heterocyclic compounds Indole-2,3-dione derivatives variously substituted hydrazones with antimicrobial activity. Bol. Soc. Ital. Biol. Sper., 63, 827-830 (1987)
|
12 |
NIAZI S., In Textbook of Biopharmaceutics and Clinical Pharmacokinetics, Appleton-Century-Crofts, New York, p. 151 (1992)
|
13 |
Ehud, K., Margalith, E., and Winer, B., Structure activity relations of thiosemicarbazones on vaccinia virus and IBT-dependent mutant. J. Antimicrob. Chemotherap., 2, 255-260 (1976)
DOI
|
14 |
Mondell, G. L. and Sande, M. A., In Gilman, A. G., Rull, T. W., Nies, A. S. and Taylor, P., The Pharmaceutical Basis of Therapeutics, 8th Ed., Pregamon press, New York , p.1147 (1991)
|
15 |
Seydel, J. K. and Schaper, K.J., The problem of resistance in the treatment of Mycobacterium infections: new experimental results and combinations for the treatment of tuberculosis and leprosy. Pharmazie in unserer Zeit, 24, 313 (1995)
DOI
ScienceOn
|
16 |
Tomioka, H., Prospects for development of new antituberculous drugs. Kekkaku, 77, 573-584 (2002)
PUBMED
|
17 |
Dye, C., Williams, B. G., Espinal, M. A., and Raviglions, M. C., Erasing the Worlds Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis. Science, 295, 2042-2046 (2002)
DOI
PUBMED
ScienceOn
|
18 |
Petrini, B. and Hoffiner, S., Drug-resistant and multidrugresistant tubercle bacilli. International Journal of Antimicrobial Agents, 13, 293-97 (1999)
|
19 |
Pablos-Mendez, A., Gowda, D. K., and Frieden, T. R., Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Bull World Health Organ, 80, 489-495 (2002)
PUBMED
|
20 |
Buu-Hoi, N. P., Xuong, N. D., Nam, N. H., Binon, F., and Royer, R., Tuberculostatic hydrazides and their derivatives. J. Chem. Soc., 1358-1364 (1953)
DOI
|
21 |
Daisley, R. W. and Shah, V. K., Synthesis and antibacterial activity of some 5-nitro-3-phenyliminoindole-2(3H)-one and their N-Mannich bases. J. Pharm. Sci., 73, 407-408 (1984)
DOI
PUBMED
|
22 |
El-Sebai, A. I., Soliman, R., and Rida, S. M., Synthesis of some new acid hydrazides structurally related to certain tuberculostatic agents. Egypt. J. Pharm. Sci., 14, 67-73 (1973)
|
23 |
Dye, C. and Williams, B. G., Criteria for the control of drugresistant tuberculosis. Proc. Natl. Acad. Sci. USA, 97, 8180-8185 (2000)
DOI
ScienceOn
|
24 |
Leo, A. J., Calculating log Poct from structures. Chem. Rev., 93, 1281-1306 (1993)
DOI
ScienceOn
|
25 |
Conradi, R. A., Burton, P. S., and Borchardt, R. T., In Pliska, V., Testa, B. and Waterbeemd, H. (Eds.). Lipophilicity in Drug Action and Toxicology, A Series Monographs of Methods and Principles in Medicinal Chemistry. VCH. Wienheim; New york; Basel; Cambridge; Tokyo, Vol. 4, p. 233 (1996)
|
26 |
Brown, R. K., Snider, R. E., and Stevenson, M. D., Some indole derivatives tested for antitubercular activity. J. Org. Chem., 21, 261-262 (1956)
|